№ lp_1_2_22426
File format: docx
Character count: 13905
File size: 102 KB
This document serves as a template for establishing a collaborative practice agreement between pharmacists and physicians for collaborative drug therapy management (CDTM) within a healthcare team.
Year:
2025
Region / city:
United States (based on context)
Theme:
Collaborative Practice Agreement for Pharmacists
Document type:
Template
Organization:
American College of Clinical Pharmacy
Author:
Not specified
Target audience:
Healthcare providers, pharmacists, physicians
Duration of agreement:
1 year (or as determined by state/region/organization)
Approval date:
Not specified
Amendment date:
Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2023
Region / City:
United Kingdom
Subject:
Advanced Pharmacist Credentialing
Document Type:
Regulations
Organ / Institution:
Royal Pharmaceutical Society (RPS)
Author:
Royal Pharmaceutical Society
Target Audience:
Pharmacists seeking advanced credentialing
Effective Period:
From 2 May 2023
Approval Date:
2 May 2023
Date of Changes:
None mentioned
Year:
2024
Region / city:
Victoria, Australia
Topic:
Urinary Tract Infection Treatment
Document Type:
Patient Handout
Organ / Institution:
Department of Health, Victoria
Author:
Department of Health, Victoria
Target Audience:
Women and gender diverse people with female biology aged 18-65
Period of validity:
March 2024
Approval date:
March 2024
Date of amendments:
N/A
Contextual Description:
Patient handout providing details about treatment, eligibility, and self-care for uncomplicated urinary tract infection under a pilot program for community pharmacists.
Version:
REDACTED
Year:
2016
Target Environment Name:
VA Mobile Framework (VAMF)
Version Number:
REDACTED
Release Date:
02/17/2016
Servers Affected:
REDACTED
JIRA Project:
Ask A Pharmacist (AAP)
Link to JIRA:
REDACTED
Description:
Ask A Pharmacist is a mobile application designed to supplement the current mobile caregiver application with a FAQ archive and secure messaging system to facilitate communication with pharmacy staff.
SCM Tool:
Atlassian
JIRA:
Tracking bugs, enhancements, user stories, and tasks
Stash / Git:
Managing source code
Jenkins:
Building deployment packages
Wiki:
Storing documents relevant to this release
Note:
Contact Information
POC Type:
Development Point of Contact
Name:
REDACTED
VA E-mail Address:
REDACTED
Phone Number:
REDACTED
Release Inventory:
REDACTED
Electronic Media Released:
REDACTED
Physical Media Released:
Not applicable
Associated Supporting Documentation:
REDACTED
Year:
2025/2026
Region / City:
England
Topic:
Pharmacy Training, Healthcare
Document Type:
Training Plan
Organization:
NHS England
Author:
Not specified
Target Audience:
Foundation Trainee Pharmacists, Supervisors
Period of Validity:
2025/2026
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2023
Region / City:
Victoria
Topic:
Community Pharmacy, Pilot Program, Healthcare Services
Document Type:
Official Information Pack
Organization:
Department of Health
Author:
Not specified
Target Audience:
Community Pharmacists, Pharmacy Owners, Healthcare Providers
Period of Operation:
October 2023 - June 2025
Approval Date:
Not specified
Date of Last Update:
February 2025
Year:
2024
Region / City:
United Kingdom
Topic:
Advanced Pharmacist Critical Care Curriculum
Document Type:
Consultation Summary
Organization:
Royal Pharmaceutical Society (RPS), UK Clinical Pharmacy Association (UKCPA)
Author:
RPS Critical Care Curriculum Task and Finish Group
Target Audience:
Pharmacists, Healthcare Professionals in Critical Care, Policy Makers
Period of Application:
2024
Approval Date:
April 2024
Modification Date:
April 2024
Year:
2024
Region / city:
England
Subject:
Mental health, pharmacy education, curriculum development
Document type:
Consultation summary
Organization / institution:
Royal Pharmaceutical Society (RPS)
Author:
Not specified
Target audience:
Mental health pharmacists, educational professionals, healthcare providers
Period of validity:
14th February - 12th March 2024
Approval date:
Not specified
Amendment date:
March - April 2024
Year:
2019
Region / City:
United Kingdom
Subject:
Pharmacy Services
Document Type:
Standard Operating Procedure
Organization:
NHS
Author:
NHS England
Target Audience:
Community Pharmacists, Dispensary Staff
Period of Implementation:
From 29th October 2019
Approval Date:
29th October 2019
Document Changes:
No changes listed
Version:
Final
Note:
Year
Organisation:
PillBox Chemists Ltd
Document type:
Declaration and terms and conditions form
Subject:
Fitness to practice, booking conditions, and professional obligations of locum pharmacists
Intended audience:
Locum pharmacists
Regulatory framework:
General Pharmaceutical Council standards and NHS England requirements
Geographical scope:
United Kingdom
Required submission time:
At least 2 days prior to booking, or on arrival for emergency bookings
Accreditation areas:
Repeat Dispensing, Safeguarding Level 2, MURs, NMS, EPS, SCR, Seasonal Flu Vaccination
Compliance areas:
Clinical governance, standard operating procedures, ordering policies, time keeping, pharmacy services
Declaration elements:
Fitness to practice, DBS self-declaration, indemnity insurance, disciplinary history
Contact method:
Email and fax submission to company bookings office
Year:
2011
Region / City:
Washington, D.C.
Topic:
Pharmacist License Requirements
Document Type:
Checklist
Organ / Institution:
District of Columbia Board of Pharmacy
Author:
Not specified
Target Audience:
Pharmacists and Pharmacy Interns
Period of Action:
Ongoing
Approval Date:
Not specified
Date of Amendments:
Not specified
Year:
2022
Region / city:
Tullamore, Midland Region
Field:
Healthcare, Pharmacist recruitment
Document type:
Application form
Organization / institution:
Health Service Executive
Author:
Health Service Executive
Target audience:
Job applicants
Period of validity:
Until application deadline
Approval date:
N/A
Date of amendments:
N/A
Contextual description:
Application form for the position of Pharmacist Chief II in the Dispensary Services at Midland Regional Hospital Tullamore, outlining eligibility criteria and application requirements.
Year:
2023
Region:
Western Australia
Type of document:
Structured Administration and Supply Arrangement (SASA)
Authority:
Chief Executive Officer of Health under Part 6 of the Medicines and Poisons Regulations 2016
Issuer:
Dr Andrew Robertson, Chief Health Officer, Department of Health WA
Practitioner:
Registered Pharmacists with approved training
Practice setting:
Registered community pharmacies in Western Australia
Approved activity:
Supply of Schedule 4 oral antibiotics for uncomplicated urinary tract infection
Approved medicines:
Nitrofurantoin, Trimethoprim
Target population:
Female patients aged 18–65 with uncomplicated UTI
Conditions:
Compliance with training, registration, clinical criteria, record-keeping, and regulatory requirements
Date issued:
24 July 2023
Contact:
Medicines and Poisons Regulation Branch, [email protected]
Note:
, Number 034/7-2023
Year:
2024
Region / City:
Leicester, United Kingdom
Topic:
Pharmacist Independent Prescribing
Document Type:
Application Form
Organization:
University of Leicester
Author:
University of Leicester
Target Audience:
Pharmacists, Pharmacist Trainees
Validity Period:
Until completion of the course
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2024
Region / City:
New Zealand
Theme:
Employment Agreement
Document Type:
Collective Employment Agreement
Organization:
Te Whatu Ora – Health New Zealand
Author:
Not specified
Target Audience:
Employees of Te Whatu Ora – Health New Zealand
Period of Validity:
2 April 2024 to 30 November 2025
Date of Approval:
Not specified
Date of Amendments:
Not specified
Year:
2017
Region / City:
Queensland
Topic:
Network Access Control, ICT Infrastructure
Document Type:
Guideline
Organization / Institution:
Queensland Government Chief Information Office
Author:
Strategic Transformation
Target Audience:
Queensland Government departments, Solution architects, CIOs, Technical SMEs
Period of Validity:
N/A
Approval Date:
December 2017
Date of Changes:
N/A
Year:
2009
Region / City:
EU
Theme:
Fuel Cells, Hydrogen, Research
Document Type:
Guide
Organization / Institution:
Fuel Cells and Hydrogen Joint Undertaking (FCH JU)
Author:
FCH JU Governing Board
Target Audience:
Researchers, Institutions, SMEs, Industry
Period of Validity:
N/A
Approval Date:
15 May 2009
Amendments Date:
N/A
Year:
2026
Region / City:
United States
Theme:
Collaborative Care Program (CoCM) Documentation
Document Type:
Template
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Behavioral health care providers, healthcare professionals involved in CoCM
Validity Period:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2026
Organization:
Michael J. Fox Foundation (MJFF)
Document Type:
Application Guidelines
Audience:
Researchers submitting Letters of Intent (LOI)
Submission Method:
Online via MJFF Grant Portal
Project Focus:
Human Parkinson’s Disease research
Included Sections:
Project Information, Team Information, Proposal Template, Team Summary, Preliminary Data, Letter of Commitment
Additional Resources:
ASAP Collaborative Network Grant Portal Registration Guide, Team Application & Budget Guidelines
Year:
2024
Region / City:
UK
Theme:
Research Grants
Document Type:
Application Guidelines
Institution:
BAM (British Academy of Management)
Author:
BAM Grants Team
Target Audience:
Principal Investigators, Co-Investigators, Academic Researchers
Period of Validity:
Until March 2024
Approval Date:
Not provided
Date of Changes:
Not provided